These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 8361757)

  • 21. Human Harvey-ras is biochemically different from Kirsten- or N-ras.
    Carbone A; Gusella GL; Radzioch D; Varesio L
    Oncogene; 1991 May; 6(5):731-7. PubMed ID: 1905005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
    Xin H; Geng Y; Pramanik R; Choubey D
    J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ras-independent activation of Rel-family transcription factors by UVB and TPA in cultured keratinocytes.
    Tobin D; Nilsson M; Toftgård R
    Oncogene; 1996 Feb; 12(4):785-93. PubMed ID: 8632900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
    Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
    Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
    Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
    Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase C alpha activates RAF-1 by direct phosphorylation.
    Kolch W; Heidecker G; Kochs G; Hummel R; Vahidi H; Mischak H; Finkenzeller G; Marmé D; Rapp UR
    Nature; 1993 Jul; 364(6434):249-52. PubMed ID: 8321321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An essential role for Rac in Ras transformation.
    Qiu RG; Chen J; Kirn D; McCormick F; Symons M
    Nature; 1995 Mar; 374(6521):457-9. PubMed ID: 7700355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
    Gallagher AP; Burnett AK; Bowen DT; Darley RL
    Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
    Araujo JC; Doniger J; Stöppler H; Sadaie MR; Rosenthal LJ
    Oncogene; 1997 Feb; 14(8):937-43. PubMed ID: 9050993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway.
    Lo LW; Cheng JJ; Chiu JJ; Wung BS; Liu YC; Wang DL
    J Cell Physiol; 2001 Sep; 188(3):304-12. PubMed ID: 11473356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
    Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
    Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant.
    Rapp UR; Troppmair J; Beck T; Birrer MJ
    Oncogene; 1994 Dec; 9(12):3493-8. PubMed ID: 7970709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K.
    Ramírez de Molina A; Penalva V; Lucas L; Lacal JC
    Oncogene; 2002 Jan; 21(6):937-46. PubMed ID: 11840339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
    Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
    Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ras- and Raf-mediated regulation of transforming growth factor beta 1 gene expression by ligands of tyrosine kinase receptors in PC12 cells.
    Cosgaya JM; Aranda A
    Oncogene; 1996 Jun; 12(12):2651-60. PubMed ID: 8700524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposite role of Ras in tumor necrosis factor-alpha-induced cell cycle regulation: competition for Raf kinase.
    Park SJ; Kim YY; Lim JY; Seo GJ; Kim J; Park SI; Park BJ
    Biochem Biophys Res Commun; 2001 Oct; 287(5):1140-7. PubMed ID: 11587542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene.
    Li Y; White R
    Cancer Res; 1996 Jun; 56(12):2872-6. PubMed ID: 8665528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.